title: Combination immunotherapy breakthrough for melanoma.
authors.forename: Vicki
authors.initials: V
authors.lastname: Brower
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D018572:Disease-Free Survival; D004359:Drug Therapy, Combination; D007167:Immunotherapy / Q000379:methods; D000074324:Ipilimumab; D008545:Melanoma / Q000401:mortality / Q000473:pathology / Q000628:therapy; D009361:Neoplasm Invasiveness / Q000473:pathology; D000077594:Nivolumab; D011379:Prognosis; D012878:Skin Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000074324:Ipilimumab; D000077594:Nivolumab